ORCA BIO

Lobbying client · California · filed 2026 to 2026

Development of high-precision cell therapies for treating cancer and autoimmune disease

$20,000 Reported spend

2 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 2 filings. Everything on this page is grouped by the client's LDA id (72884), not by name.

Firms hired 1

ADAMS AND REESE, LLP $20,000 2 filings

Reported by year 1 year

2026 $20,000 2 filings

Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 5

Executive Office of the President (EOP) 1
Food & Drug Administration (FDA) 1
Health & Human Services, Dept of (HHS) 1
HOUSE OF REPRESENTATIVES 1
SENATE 1

Recent filings 2 total

Q2

ADAMS AND REESE, LLP

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $20,000 income · posted Jul 14, 2026

View → RR

ADAMS AND REESE, LLP

2nd Quarter (Apr 1 - June 30) 2026 · posted Apr 28, 2026

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.